KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Free Cash Flow (2016 - 2025)

Biogen has reported Free Cash Flow over the past 17 years, most recently at $468.0 million for Q4 2025.

  • Quarterly results put Free Cash Flow at $468.0 million for Q4 2025, down 35.14% from a year ago — trailing twelve months through Dec 2025 was $2.1 billion (down 24.65% YoY), and the annual figure for FY2025 was $2.1 billion, down 24.65%.
  • Free Cash Flow for Q4 2025 was $468.0 million at Biogen, down from $1.2 billion in the prior quarter.
  • Over the last five years, Free Cash Flow for BIIB hit a ceiling of $1.2 billion in Q3 2025 and a floor of -$261.4 million in Q4 2022.
  • Median Free Cash Flow over the past 5 years was $555.2 million (2023), compared with a mean of $528.4 million.
  • Biggest five-year swings in Free Cash Flow: crashed 133.23% in 2022 and later soared 1469.26% in 2024.
  • Biogen's Free Cash Flow stood at $786.7 million in 2021, then crashed by 133.23% to -$261.4 million in 2022, then surged by 79.84% to -$52.7 million in 2023, then soared by 1469.26% to $721.6 million in 2024, then plummeted by 35.14% to $468.0 million in 2025.
  • The last three reported values for Free Cash Flow were $468.0 million (Q4 2025), $1.2 billion (Q3 2025), and $134.3 million (Q2 2025) per Business Quant data.